Lombardo Franco

Title: Lombardo Franco: Innovator in Cholesteryl Ester Transfer Protein Inhibitors

Introduction

Lombardo Franco is a notable inventor based in Gales Ferry, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of cholesteryl ester transfer protein (CETP) inhibitors. His innovative work focuses on enhancing the solubility and bioavailability of these compounds.

Latest Patents

Franco holds a patent for "Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors." This patent describes formulations that improve the solubility and bioavailability of CETP inhibitors in a lipophilic vehicle, which may include digestible oils, lipophilic solvents, or surfactants. The preferred compositions are self-emulsifying or self-microemulsifying, showcasing his commitment to advancing pharmaceutical formulations.

Career Highlights

Lombardo Franco is associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to the development of innovative therapies that address critical health issues. With a focus on improving drug delivery systems, Franco's research has the potential to impact patient outcomes significantly.

Collaborations

Franco has collaborated with esteemed colleagues, including Michael Jon Gumkowski and Sharad Murdande. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Lombardo Franco's contributions to the field of CETP inhibitors exemplify the importance of innovation in pharmaceuticals. His patent and work at Pfizer Corporation highlight his dedication to improving drug formulations and patient care. Through his efforts, Franco continues to make a meaningful impact in the world of medicine.